Thyrocare Technologies Limited has informed the Exchange about Schedule of conference call for the analysts/investors to discuss on the Company s Unaudited financial results for the quarter and nine m...

January 16, 2025

To, National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 (SYMBOL: THYROCARE)

BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001 (SCRIP CODE 539871)

Sub: Invite for Earnings Conference Call under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/Madam,

Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to intimate that a conference call for the analysts/investors is arranged by our management to discuss the Company’s Unaudited financial results for the quarter and nine months ended December 31, 2024, on Thursday January 23, 2025, at 5:00 pm. (IST).

Dial-in details are given in the copy of the enclosed invite.

This is for your information and records.

For Thyrocare Technologies Limited

Ramjee Dorai Company Secretary and Compliance Officer

Encl: A/a

Thyrocare Q3FY25 Earnings Call Thursday, January 23, 2025, 5:00 PM IST

Thyrocare Technologies Limited Invites you to interact with the senior management on Q3FY25 earnings

Speakers:

Mr. Rahul Guha, MD & CEO Mr. Alok Kumar Jagnani, CFO Mr. Nitin Chugh, CCO Mr. Kapil Gupta, Manager - Strategy & Investor Relations

Conference Call Details

Dial in Details:

Universal Access

For Thyrocare’s conference call, Thursday, January 23, 2025, 5:00pm IST

+91 22 6280 1408 +91 22 7115 8296

Copy this URL in your browser (for early registration)

https://services.choruscall.in/DiamondPassRegistration/register?confir mationNumber=0617020&linkSecurityString=439824244

Webcast Link

https://links.ccwebcast.com/?EventId=THY230125